IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
EFFICACY RESULTS FROM THE RANDOMISED PHASE III OPTIMAL (CTONG 0802) STUDY COMPARING FIRST-LINE ERLOTINIB VERSUS CARBOPLATIN (CBDCA) PLUS GEMCITABINE (GEM), IN CHINESE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (PTS) WITH EGFR ACTIVATING MUTATIONS
Zhou, C.1; Wu, Y-L.2,3; Chen, G.4; Feng, J.5; Liu, X.6; Wang, C.7; Zhang, S.8; Wang, J.9; Zhou, S.1; Ren, S.1; OPTIMAL Investigators
刊名ANNALS OF ONCOLOGY
2010-10-01
suppl.8页:6-6
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
语种英语
WOS记录号WOS:000283115900014
Citation statistics
Cited Times:34[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/55553
Collection北京大学临床肿瘤学院
作者单位1.Beijing Chest Hosp, Beijing, Peoples R China
2.Tongji Univ, Shanghai Pulm Hosp, Shanghai 200092, Peoples R China
3.Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China
4.Harbin Med Coll, Canc Hosp, Harbin, Peoples R China
5.Jiangsu Prov Canc Hosp, Nanjing, Peoples R China
6.Tianjin Canc Hosp, Tianjin, Peoples R China
7.Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China
8.Acad Mil Med Sci, Hosp 307, Ctr Canc, Beijing, Peoples R China
9.Peking Univ, Sch Oncol, Beijing Canc Hosp, Beijing 100871, Peoples R China
Recommended Citation
GB/T 7714
Zhou, C.,Wu, Y-L.,Chen, G.,et al. EFFICACY RESULTS FROM THE RANDOMISED PHASE III OPTIMAL (CTONG 0802) STUDY COMPARING FIRST-LINE ERLOTINIB VERSUS CARBOPLATIN (CBDCA) PLUS GEMCITABINE (GEM), IN CHINESE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (PTS) WITH EGFR ACTIVATING MUTATIONS[J]. ANNALS OF ONCOLOGY,2010,suppl.8:6-6.
APA Zhou, C..,Wu, Y-L..,Chen, G..,Feng, J..,Liu, X..,...&OPTIMAL Investigators.(2010).EFFICACY RESULTS FROM THE RANDOMISED PHASE III OPTIMAL (CTONG 0802) STUDY COMPARING FIRST-LINE ERLOTINIB VERSUS CARBOPLATIN (CBDCA) PLUS GEMCITABINE (GEM), IN CHINESE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (PTS) WITH EGFR ACTIVATING MUTATIONS.ANNALS OF ONCOLOGY,suppl.8,6-6.
MLA Zhou, C.,et al."EFFICACY RESULTS FROM THE RANDOMISED PHASE III OPTIMAL (CTONG 0802) STUDY COMPARING FIRST-LINE ERLOTINIB VERSUS CARBOPLATIN (CBDCA) PLUS GEMCITABINE (GEM), IN CHINESE ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC) PATIENTS (PTS) WITH EGFR ACTIVATING MUTATIONS".ANNALS OF ONCOLOGY suppl.8(2010):6-6.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Zhou, C.]'s Articles
[Wu, Y-L.]'s Articles
[Chen, G.]'s Articles
百度学术
百度学术Similar articles in
[Zhou, C.]'s Articles
[Wu, Y-L.]'s Articles
[Chen, G.]'s Articles
必应学术
必应学术Similar articles in
[Zhou, C.]'s Articles
[Wu, Y-L.]'s Articles
[Chen, G.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.